Rising Pharma Holding, Inc.: Duloxetine DR Capsules USP 60 mg, a) 30 count, b)
Recall reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit. Recalled by Rising Pharma Holding, Inc.. Distribution: Nationwide.. Classification (Class II — potential health risk). Affected lots/NDC/dates: a) 30s; DT6023059A, DT6023060A, DT6023065A, DT6023069A, DT6023070A, exp. date Jan-25, DT6023080A, exp. date Feb-25, DT60. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report